rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2008-10-17
|
pubmed:abstractText |
A large variety of adverse reactions are well known to frequently occur during chemotherapy and radiotherapy in oncology. Specific medications exist to target individual side effects. The aim of this study was to explore in a pilot trial whether supplementation with French maritime pine bark extract Pycnogenol could alleviate side effects and improve patient's quality of life.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0031-0808
|
pubmed:author |
pubmed-author:BelcaroGG,
pubmed-author:CacchioMM,
pubmed-author:CesaroneM RMR,
pubmed-author:Di RenzoAA,
pubmed-author:DugallMM,
pubmed-author:GenovesiDD,
pubmed-author:GizziGG,
pubmed-author:IppolitoEE,
pubmed-author:LeddaAA,
pubmed-author:PellegrinoJJ,
pubmed-author:RicciAA,
pubmed-author:StuardSS,
pubmed-author:VinciguerraGG
|
pubmed:issnType |
Print
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
227-34
|
pubmed:meshHeading |
pubmed-meshheading:18927527-Adult,
pubmed-meshheading:18927527-Aged,
pubmed-meshheading:18927527-Antineoplastic Agents,
pubmed-meshheading:18927527-Female,
pubmed-meshheading:18927527-Flavonoids,
pubmed-meshheading:18927527-Humans,
pubmed-meshheading:18927527-Karnofsky Performance Status,
pubmed-meshheading:18927527-Male,
pubmed-meshheading:18927527-Middle Aged,
pubmed-meshheading:18927527-Neoplasms,
pubmed-meshheading:18927527-Pilot Projects,
pubmed-meshheading:18927527-Quality of Life,
pubmed-meshheading:18927527-Radiotherapy,
pubmed-meshheading:18927527-Single-Blind Method,
pubmed-meshheading:18927527-Time Factors,
pubmed-meshheading:18927527-Treatment Outcome
|
pubmed:year |
2008
|
pubmed:articleTitle |
Pycnogenol may alleviate adverse effects in oncologic treatment.
|
pubmed:affiliation |
Vascular Labs and Physiology, Department of Biomedical Sciences, Gabriele D'Annunzio University, Chieti-Pescara, Chieti, Italy. cardres@abol.it
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|